Incretin- Market Report

China Incretin- Industry Market Research Report 2023-2029

  • POSTDATE：Sep 27, 2023
  • PAGES：170
  • REPORT CODE：GMM1816190
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Incretin- industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca

    • Boehringer Ingelheim

    • Novartis

    • Merck

    • Eli Lilly

    • Sanofi

    • GlaxoSmithKline

    • Takeda Pharmaceutical

    By Type:

    • by Rormulation

    • by Drug Types

    • Oral Drugs

    • Injectable Drugs

    • Peptide-1 Receptor (GLP-1) Agonists

    • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

    By Application:

    • Independent Pharmacies

    • Drug Store

    • Hospital Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Incretin- Market Overview 2018-2029

    • 1.1 China Incretin- Industry Development Overview

    • 1.2 China Incretin- Industry Development History

    • 1.3 China Incretin- Industry Market Size (2018-2029)

    • 1.4 China Incretin- Market Analysis by Type from Production Side

      • 1.4.1 China Incretin- Production Volume, Production Value and Growth Rate of by Rormulation (2018-2029)

      • 1.4.2 China Incretin- Production Volume, Production Value and Growth Rate of by Drug Types (2018-2029)

      • 1.4.3 China Incretin- Production Volume, Production Value and Growth Rate of Oral Drugs (2018-2029)

      • 1.4.4 China Incretin- Production Volume, Production Value and Growth Rate of Injectable Drugs (2018-2029)

      • 1.4.5 China Incretin- Production Volume, Production Value and Growth Rate of Peptide-1 Receptor (GLP-1) Agonists (2018-2029)

      • 1.4.6 China Incretin- Production Volume, Production Value and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (2018-2029)

    • 1.5 China Incretin- Market Analysis by Application from Consumption End

      • 1.5.1 China Incretin- Sales Volume, Sales Value and Growth Rate of Independent Pharmacies (2018-2029)

      • 1.5.2 China Incretin- Sales Volume, Sales Value and Growth Rate of Drug Store (2018-2029)

      • 1.5.3 China Incretin- Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • 1.6 China Incretin- Market Analysis by Region

      • 1.6.1 North China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Incretin- Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Incretin- Market Size and Growth Rate from 2018-2029

    Chapter 2 China Incretin- Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Incretin- Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Incretin- Market Status and Competition Analysis in 2023

      • 2.2.3 China Incretin- Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Incretin- Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Incretin- Industry Development

    Chapter 3 Incretin-Industry Chain Analysis

    • 3.1 Incretin- Industry Chain

    • 3.2 Incretin- Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Incretin- Market

    • 3.3 Incretin- Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Incretin- Market

    Chapter 4 China Incretin- Market, by Type

    • 4.1 China Incretin- Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Incretin- Total Production Volume and Growth Rate from Production Side

    • 4.5 China Incretin- Production Volume and Growth Rate, by Type

      • 4.5.1 China Incretin- Production Volume and Growth Rate of by Rormulation

      • 4.5.2 China Incretin- Production Volume and Growth Rate of by Drug Types

      • 4.5.3 China Incretin- Production Volume and Growth Rate of Oral Drugs

      • 4.5.4 China Incretin- Production Volume and Growth Rate of Injectable Drugs

      • 4.5.5 China Incretin- Production Volume and Growth Rate of Peptide-1 Receptor (GLP-1) Agonists

      • 4.5.6 China Incretin- Production Volume and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

    Chapter 5 China Incretin- Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Incretin- Total Market Size and Growth Rate from Consumption End

    • 5.5 China Incretin- Market Size and Growth Rate, by Application

      • 5.5.1 China Incretin- Market Size and Growth Rate of Independent Pharmacies

      • 5.5.2 China Incretin- Market Size and Growth Rate of Drug Store

      • 5.5.3 China Incretin- Market Size and Growth Rate of Hospital Pharmacies

    Chapter 6 China Incretin- Market, by Region

    • 6.1 China Incretin- Production Volume and Production Value, by Region

    • 6.2 China Incretin- Sales Volume and Sales Value, by Region

    Chapter 7 North China Incretin- Market Analysis

    • 7.1 North China Incretin- Market, by Type

    • 7.2 North China Incretin- Market, by Application

    Chapter 8 Central China Incretin- Market Analysis

    • 8.1 Central China Incretin- Market, by Type

    • 8.2 Central China Incretin- Market, by Application

    Chapter 9 South China Incretin- Market Analysis

    • 9.1 South China Incretin- Market, by Type

    • 9.2 South China Incretin- Market, by Application

    Chapter 10 East China Incretin- Market Analysis

    • 10.1 East China Incretin- Market, by Type

    • 10.2 East China Incretin- Market, by Application

    Chapter 11 Northeast China Incretin- Market Analysis

    • 11.1 Northeast China Incretin- Market, by Type

    • 11.2 Northeast China Incretin- Market, by Application

    Chapter 12 Southwest China Incretin- Market Analysis

    • 12.1 Southwest China Incretin- Market, by Type

    • 12.2 Southwest China Incretin- Market, by Application

    Chapter 13 Northwest China Incretin- Market Analysis

    • 13.1 Northwest China Incretin- Market, by Type

    • 13.2 Northwest China Incretin- Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca

        • 14.1.1 AstraZeneca Company Profile

        • 14.1.2 AstraZeneca Incretin- Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim

        • 14.2.1 Boehringer Ingelheim Company Profile

        • 14.2.2 Boehringer Ingelheim Incretin- Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis

        • 14.3.1 Novartis Company Profile

        • 14.3.2 Novartis Incretin- Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck

        • 14.4.1 Merck Company Profile

        • 14.4.2 Merck Incretin- Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Eli Lilly

        • 14.5.1 Eli Lilly Company Profile

        • 14.5.2 Eli Lilly Incretin- Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi

        • 14.6.1 Sanofi Company Profile

        • 14.6.2 Sanofi Incretin- Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 GlaxoSmithKline

        • 14.7.1 GlaxoSmithKline Company Profile

        • 14.7.2 GlaxoSmithKline Incretin- Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Takeda Pharmaceutical

        • 14.8.1 Takeda Pharmaceutical Company Profile

        • 14.8.2 Takeda Pharmaceutical Incretin- Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Incretin- Industry Research Conclusions

    • 15.2 Incretin- Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Incretin- Industry Market Size (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of by Rormulation (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of by Drug Types (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of Oral Drugs (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of Injectable Drugs (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of Peptide-1 Receptor (GLP-1) Agonists (2018-2029)

    • Figure China Incretin- Production Volume, Production Value and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (2018-2029)

    • Figure China Incretin- Sales Volume, Sales Value and Growth Rate of Independent Pharmacies (2018-2029)

    • Figure China Incretin- Sales Volume, Sales Value and Growth Rate of Drug Store (2018-2029)

    • Figure China Incretin- Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure North China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure Central China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure South China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure East China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Incretin- Market Size and Growth Rate from 2018-2029

    • Figure Incretin- Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Incretin- Market Share by Type in 2018

    • Figure China Incretin- Market Share by Type in 2023

    • Figure China Incretin- Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of by Rormulation (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of by Drug Types (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of Oral Drugs (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of Injectable Drugs (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of Peptide-1 Receptor (GLP-1) Agonists (2018-2023)

    • Figure China Incretin- Production Volume and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (2018-2023)

    • Figure China Incretin- Market Share by Application in 2018

    • Figure China Incretin- Market Share by Application in 2023

    • Figure China Incretin- Total Market Size and Growth Rate from Consumption End

    • Figure China Incretin- Market Size and Growth Rate of Independent Pharmacies (2018-2023)

    • Figure China Incretin- Market Size and Growth Rate of Drug Store (2018-2023)

    • Figure China Incretin- Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Table China Incretin- Production Volume by Region (2018-2023)

    • Table China Incretin- Production Volume Share by Region (2018-2023)

    • Figure China Incretin- Production Volume Share by Region (2018-2023)

    • Table China Incretin- Production Value by Region (2018-2023)

    • Table China Incretin- Production Value Share by Region (2018-2023)

    • Figure China Incretin- Production Value Share by Region (2018-2023)

    • Table China Incretin- Sales Volume by Region (2018-2023)

    • Table China Incretin- Sales Volume Share by Region (2018-2023)

    • Figure China Incretin- Sales Volume Share by Region (2018-2023)

    • Table China Incretin- Sales Value by Region (2018-2023)

    • Table China Incretin- Sales Value Share by Region (2018-2023)

    • Figure China Incretin- Sales Value Share by Region (2018-2023)

    • Table North China Incretin- Production Volume by Type (2018-2023)

    • Table North China Incretin- Production Volume Share by Type (2018-2023)

    • Figure North China Incretin- Production Volume Share by Type (2018-2023)

    • Table North China Incretin- Sales Volume by Application (2018-2023)

    • Table North China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure North China Incretin- Sales Volume Share by Application (2018-2023)

    • Table Central China Incretin- Production Volume by Type (2018-2023)

    • Table Central China Incretin- Production Volume Share by Type (2018-2023)

    • Figure Central China Incretin- Production Volume Share by Type (2018-2023)

    • Table Central China Incretin- Sales Volume by Application (2018-2023)

    • Table Central China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure Central China Incretin- Sales Volume Share by Application (2018-2023)

    • Table South China Incretin- Production Volume by Type (2018-2023)

    • Table South China Incretin- Production Volume Share by Type (2018-2023)

    • Figure South China Incretin- Production Volume Share by Type (2018-2023)

    • Table South China Incretin- Sales Volume by Application (2018-2023)

    • Table South China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure South China Incretin- Sales Volume Share by Application (2018-2023)

    • Table East China Incretin- Production Volume by Type (2018-2023)

    • Table East China Incretin- Production Volume Share by Type (2018-2023)

    • Figure East China Incretin- Production Volume Share by Type (2018-2023)

    • Table East China Incretin- Sales Volume by Application (2018-2023)

    • Table East China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure East China Incretin- Sales Volume Share by Application (2018-2023)

    • Table Northeast China Incretin- Production Volume by Type (2018-2023)

    • Table Northeast China Incretin- Production Volume Share by Type (2018-2023)

    • Figure Northeast China Incretin- Production Volume Share by Type (2018-2023)

    • Table Northeast China Incretin- Sales Volume by Application (2018-2023)

    • Table Northeast China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Incretin- Sales Volume Share by Application (2018-2023)

    • Table Southwest China Incretin- Production Volume by Type (2018-2023)

    • Table Southwest China Incretin- Production Volume Share by Type (2018-2023)

    • Figure Southwest China Incretin- Production Volume Share by Type (2018-2023)

    • Table Southwest China Incretin- Sales Volume by Application (2018-2023)

    • Table Southwest China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Incretin- Sales Volume Share by Application (2018-2023)

    • Table Northwest China Incretin- Production Volume by Type (2018-2023)

    • Table Northwest China Incretin- Production Volume Share by Type (2018-2023)

    • Figure Northwest China Incretin- Production Volume Share by Type (2018-2023)

    • Table Northwest China Incretin- Sales Volume by Application (2018-2023)

    • Table Northwest China Incretin- Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Incretin- Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Incretin- Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Incretin- Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Incretin- Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Incretin- Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Incretin- Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Incretin- Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Incretin- Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Incretin- Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US